In heart tissue, Aldo contributes to ventricular remodelling after acute myocardial infarction, and MR antagonists exert beneficial effects, reducing sudden cardiac death and hospitalisations for heart failure when used early after myocardial infarction [27,28]. The gene discussed is NR3C2; the disease is acute myocardial infarction.